0
Article |

Screening of Newborns for Cystic Fibrosis FREE

LEWIS E. GIBSON, MD
Am J Dis Child. 1980;134(10):925-926. doi:10.1001/archpedi.1980.02130220003001.
Text Size: A A A
Published online

The report by Berry et al (see p 930) raises the question of mass screening of newborns for cystic fibrosis (CF). The authors suggest that mass screening is advisable, but do not believe enough data are available to recommend the best procedure. Both of these conclusions may be questioned. The advantages of early diagnosis should be examined. Also, since their article reports the examination of 65,000 meconium specimens, and a collaborative study1 funded by the National Cystic Fibrosis Foundation reports the examination of more than 100,000 specimens, it should be possible at this point to draw some conclusions about the efficacy of various testing procedures.

It is difficult to argue that the early diagnosis of any disease is not in some way beneficial. However, one may vastly overstate the benefit. This seems to have occurred when Berry et al quoted an estimate "that up to 90% of undiagnosed CF

REFERENCES

Holzclaw DS, Berry HK, Bruns W, et al:  Meconium screening for cystic fibrosis: A collaborative study , in Cystic Fibrosis Club Abstracts. Rockville , Md, Cystic Fibrosis Foundation, 1977;, p 54.
Warwick WJ:  Ascertainment of CF in Minnesota , in Cystic Fibrosis Club Abstracts. Rockville , Md, Cystic Fibrosis Foundation, 1979;, p 88.
Warwick WJ, Pogue RE:  Missing patients with cystic fibrosis , in Cystic Fibrosis Club Abstracts. Rockville , Md, Cystic Fibrosis Foundation, 1978;, p 99.
Motoyama EK, Gibson LE, Zigas CJ:  Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve . Pediatrics 50:299-306, 1972;.
Wood RE, di Sant'Agnese PA:  Bioassays of cystic fibrosis factor . Lancet 2:1452-1453, 1973;.
Link to Article

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Holzclaw DS, Berry HK, Bruns W, et al:  Meconium screening for cystic fibrosis: A collaborative study , in Cystic Fibrosis Club Abstracts. Rockville , Md, Cystic Fibrosis Foundation, 1977;, p 54.
Warwick WJ:  Ascertainment of CF in Minnesota , in Cystic Fibrosis Club Abstracts. Rockville , Md, Cystic Fibrosis Foundation, 1979;, p 88.
Warwick WJ, Pogue RE:  Missing patients with cystic fibrosis , in Cystic Fibrosis Club Abstracts. Rockville , Md, Cystic Fibrosis Foundation, 1978;, p 99.
Motoyama EK, Gibson LE, Zigas CJ:  Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve . Pediatrics 50:299-306, 1972;.
Wood RE, di Sant'Agnese PA:  Bioassays of cystic fibrosis factor . Lancet 2:1452-1453, 1973;.
Link to Article

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.